References
- Elbachiri M, Fatima S, Bouchbika Z, Benchekroun N, Jouhadi H, Tawfiq N, Sahraoui S, Benider A. Breast cancer in men: about 40 cases and literature review. Pan Afr Med J. 2017;28:287.
- Anastasiadi Z, Lianos GD, Ignatiadou E, Harissis HV, Mitsis M. Breast cancer in young women: an overview. Updates Surg. 2017;69:313–317. doi:https://doi.org/10.1007/s13304-017-0424-1.
- Wörmann B. Breast cancer: basics, screening, diagnostics and treatment. Med Monatsschr Pharm. 2017;40:55–64.
- Boyages J. Radiation therapy and early breast cancer: current controversies. Med J Aust. 2017;207:216–222. doi:https://doi.org/10.5694/mja16.01020.
- Castaneda SA, Strasser J. Updates in the treatment of breast cancer with radiotherapy. Surg Oncol Clin N Am. 2017;26:371–382. doi:https://doi.org/10.1016/j.soc.2017.01.013.
- Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29:452–463. doi:https://doi.org/10.1016/j.ccell.2016.03.010.
- Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36:5661–5667. doi:https://doi.org/10.1038/onc.2017.184.
- Gao J, Liu L, Li G, Cai M, Tan C, Han X, Han L. LncRNA GAS5 confers the radio sensitivity of cervical cancer cells via regulating miR-106b/IER3 axis. Int J Biol Macromol. 2019;126:994–1001. doi:https://doi.org/10.1016/j.ijbiomac.2018.12.176.
- Zou Y, Yao S, Chen X, Liu D, Wang J, Yuan X, Rao J, Xiong H, Yu S, Yuan X, et al. LncRNA OIP5-AS1 regulates radioresistance by targeting DYRK1A through miR-369-3p in colorectal cancer cells. Eur J Cell Biol. 2018;97:369–378.
- Hu X, Ding D, Zhang J, Cui J. 2019. Knockdown of lncRNA HOTAIR sensitizes breast cancer cells to ionizing radiation through activating miR-218. Biosci Rep. 39. DOI:https://doi.org/10.1042/BSR20181038
- Ma HP, Wang LX, Li W, Guo HH, Wu Y, Li XY. Upregulation of LINC00504 is associated with aggressive progression and poor prognosis in non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2020;24:699–703.
- Beaton LA, Marro L, Malone S, Samiee S, Grimes S, Malone K, Wilkins RC. Investigating γ H2AX as a biomarker of radiosensitivity using flow cytometry methods. ISRN Radiol. 2013;2013:704659. doi:https://doi.org/10.5402/2013/704659.
- Dykes IM, Emanueli C. Transcriptional and post-transcriptional gene regulation by long non-coding RNA. Genomics Proteomics Bioinformatics. 2017;15:177–186. doi:https://doi.org/10.1016/j.gpb.2016.12.005.
- Ong CT, Corces VG. Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat Rev Genet. 2011;12:283–293. doi:https://doi.org/10.1038/nrg2957.
- Kostanian IA, Vonarshenko AV, Lipkin VM. [STAT1: a many-sided transcription factor]. Bioorg Khim. 2010;36:15–28.
- Adámková L, Soucková K, Kovarík J. Transcription protein STAT1: biology and relation to cancer. Folia Biol (Praha). 2007;53:1–6.
- Yan P, Luo S, Lu JY, Shen X. Cis- and trans-acting lncRNAs in pluripotency and reprogramming. Curr Opin Genet Dev. 2017;46:170–178. doi:https://doi.org/10.1016/j.gde.2017.07.009.
- Gardiner AS, Twiss JL, Perrone-Bizzozero NI. Competing interactions of RNA-binding proteins, MicroRNAs, and their targets control neuronal development and function. Biomolecules. 2015;5:2903–2918. doi:https://doi.org/10.3390/biom5042903.
- Chiyomaru T, Fukuhara S, Saini S, Majid S, Deng G, Shahryari V, Chang I, Tanaka Y, Enokida H, Nakagawa M, et al. Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells. J Biol Chem. 2014;289:12550–12565. doi:https://doi.org/10.1074/jbc.M113.488593.
- Du Z, Sun T, Hacisuleyman E, Fei T, Wang X, Brown M, Rinn JL, Lee MG, Chen Y, Kantoff PW, et al. Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer. Nat Commun. 2016;7:10982. doi:https://doi.org/10.1038/ncomms10982.
- Pan L, Li Y, Jin L, Li J, Xu A. TRPM2-AS promotes cancer cell proliferation through control of TAF15. Int J Biochem Cell Biol. 2020;120:105683. doi:https://doi.org/10.1016/j.biocel.2019.105683.
- Lin CL, Taggart AJ, Lim KH, Cygan KJ, Ferraris L, Creton R, Huang YT, Fairbrother WG. RNA structure replaces the need for U2AF2 in splicing. Genome Res. 2016;26:12–23. doi:https://doi.org/10.1101/gr.181008.114.
- Minafra L, Bravatà V, Cammarata FP, Russo G, Gilardi MC, Forte GI. Radiation gene-expression signatures in primary breast cancer cells. Anticancer Res. 2018;38:2707–2715.
- Lai Y, Chen Y, Lin Y, Ye L. Down-regulation of LncRNA CCAT1 enhances radiosensitivity via regulating miR-148b in breast cancer. Cell Biol Int. 2018;42:227–236. doi:https://doi.org/10.1002/cbin.10890.
- Feng J, Ma J, Liu S, Wang J, Chen Y. A noncoding RNA LINC00504 interacts with c-Myc to regulate tumor metabolism in colon cancer. J Cell Biochem. 2019;120:14725–14734. doi:https://doi.org/10.1002/jcb.28733.
- Liu Y, He X, Chen Y, Cao D. Long non-coding RNA LINC00504 regulates the Warburg effect in ovarian cancer through inhibition of miR-1244. Mol Cell Biochem. 2020;464:39–50. doi:https://doi.org/10.1007/s11010-019-03647-z.
- Shen Y, Gao X, Tan W, Xu T. STAT1-mediated upregulation of lncRNA LINC00174 functions a ceRNA for miR-1910-3p to facilitate colorectal carcinoma progression through regulation of TAZ. Gene. 2018;666:64–71. doi:https://doi.org/10.1016/j.gene.2018.05.001.
- Lin XL, Zhu J, Wang LM, Yan F, Sha WP, Yang HL. MiR-92b-5p inhibitor suppresses IL-18 mediated inflammatory amplification after spinal cord injury via IL-18BP up-regulation. Eur Rev Med Pharmacol Sci. 2019;23:1891–1898.
- Mohibi S, Chen X, Zhang J. Cancer the’RBP’eutics-RNA-binding proteins as therapeutic targets for cancer. Pharmacol Ther. 2019;203:107390.